In vitro activity of five new quinolones against cultivable mycobacteria.

European journal of clinical microbiology ·Vol. 6 ·No. 5 ·1987-10-00 ·Pages 572-3

Pattyn SR, Van Caekenberghe DL, Verhoeven JR

Abstract

暂无摘要

MeSH Terms

Anti-Bacterial Agents/pharmacology Ciprofloxacin/analogs & derivatives,pharmacology Fluoroquinolones Microbial Sensitivity Tests Mycobacterium/drug effects Mycobacterium tuberculosis/drug effects Norfloxacin/analogs & derivatives,pharmacology Ofloxacin Oxazines/pharmacology Pefloxacin

Chemicals

Anti-Bacterial Agents Fluoroquinolones Oxazines Pefloxacin Ciprofloxacin amifloxacin Ofloxacin Norfloxacin

Authors & Affiliations

3 authors, click to expand affiliations / ORCID

Pattyn S R

Department of Medical Microbiology, University Hospital, University of Antwerp, Belgium.

Van Caekenberghe D L

Verhoeven J R

References (2)

2 references, click to expand

Ciprofloxacin: an overview of adverse experiences.
J Antimicrob Chemother. 1986 Nov;18 Suppl D:187-93 PMID: 3542945
In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.
Antimicrob Agents Chemother. 1984 Jul;26(1):94-6 PMID: 6236748

Article Info

Journal

European journal of clinical microbiology

Abbr.

Eur J Clin Microbiol

ISSN

0722-2211

DOI

10.1007/BF02014249

Published

1987-10-00

Pages

572-3

Language

English

Region

Germany

NLM ID

8219582

Subset

External Links

PubMed source DOI: 10.1007/BF02014249

Analysis Services

In vitro activity of five new quinolones against cultivable mycobacteria.

Contact

WeChat Official Account